Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
ALAlvotech logo

Alvotech (ALVO)

NASDAQ Global Market · Currency in USD
$4.58 ▼ -0.21 (-4.38%)
At close: Oct 23, 4:00 PM ET. Market closed.
$4.59 ▲ +0.01 (+0.22%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$4.79
Open
$4.78
Day's Range
$4.56 – $4.78
52 Week Range
$2.94 – $8.50
Volume
666,200
Avg. Volume
989,904
Market Cap
$1.63B
Beta (5Y Monthly)
0.18
PE Ratio (TTM)
--
EPS (TTM)
-$0.50
Earnings Date
Nov 11, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$8.00

Profile: Alvotech

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
1,279
CEO
Lisa Graver

Alvotech, along with its various subsidiaries, is dedicated to the global development and manufacturing of biosimilar pharmaceuticals. Its product offerings span key therapeutic categories, encompassing autoimmune conditions, eye disorders, bone diseases, and cancer. A flagship program for the company is AVT02, a high-concentration biosimilar equivalent to Humira.

Earnings

Next report: Wed, Nov 11, 2026
EPS estimate -$0.02 · Revenue est. $134.22M
DateEst.Actual
Aug 19, 2026-$0.05-$0.11Miss
May 6, 2026-$0.07-$0.09Miss
Mar 18, 2026-$0.01-$0.37Miss
Nov 12, 2025-$0.03-$0.02Beat
Aug 13, 2025-$0.05$0.14Beat
May 7, 2025-$0.08$0.35Beat

Analyst view

Consensus price target
$8.00 ▲ +74.7%
Range $8.00 – $8.00
Rating: Buy
Buy 60% · Hold 40% · Sell 0%

Get free alerts on ALVO and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.